Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ISC 17536 / Glenmark
2013-002728-17: A 4 week study to evaluate efficacy, safety and tolerability of Inhaled GRC 17536 in Patients with Refractory Chronic Cough	Ongoing	2	48	Europe	GRC 17536 potassium powder for inhalation, GRC 17536 potassium,	Glenmark Pharmaceuticals SA, Glenmark Pharmaceuticals SA	Refractory Chronic Cough.